Paula Colmenero
TransNAT Programme Manager
In my role as Programme Manager I provide operational leadership for TransNAT, an international research consortium aiming to advance Nucleic-Acid Therapeutics delivery platforms. Here I work closely with academic and industry partners to drive projects forward and ensure targets are met.
Prior to this role I've gained 8 years of experience as Scientific Project Manager supporting translational medical research across the University of Oxford.
My background is in immunology, with a PhD from the Karolinska Institute and a postdoc at Stanford University. I also worked in the biotech sector, before moving to Oxford to engage in translational research.
Recent publications
-
Inflammatory disease microbiomes share a functional pathogenicity predicted by C-reactive protein.
Britton GJ. et al, (2025), bioRxiv
-
Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes.
Thompson KN. et al, (2023), Sci Transl Med, 15
-
C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
Hornum L. et al, (2017), PLoS One, 12
-
Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis.
Söderström K. et al, (2010), Proc Natl Acad Sci U S A, 107, 13028 - 13033
-
Natural killer cells trigger differentiation of monocytes into dendritic cells.
Zhang AL. et al, (2007), Blood, 110, 2484 - 2493